Search clinical trials for: HER2 mutations
Total 3945 results
-
Daiichi SankyoAstraZenecaCompletedAdenocarcinoma Gastric Stage IV With Metastases | Adenocarcinoma - GEJUnited States, Spain, Belgium, Italy, United Kingdom
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedBreast Cancer FemaleRussian Federation
-
Daiichi Sankyo Co., Ltd.AstraZeneca; Daiichi Sankyo, Inc.CompletedAdvanced Solid TumorsUnited States, Japan
-
Daiichi Sankyo Co., Ltd.AstraZenecaCompletedNeoplasm MetastasisKorea, Republic of, Taiwan, Japan
-
UNICANCERDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyActive, not recruiting
-
Jazz PharmaceuticalsActive, not recruitingHER2+/HR+ Breast CancerUnited States, Spain, Canada
-
Seagen Inc.National Cancer Institute (NCI); Academic and Community Cancer Research UnitedCompletedMetastatic Colorectal AdenocarcinomaUnited States, Spain, Belgium, France, Italy
-
Armando GiulianoWithdrawnBreast Cancer | HER2-positive Breast CancerUnited States
-
Taiho Oncology, Inc.TerminatedAdvanced Solid Tumors With HER2 Abnormalities | Advanced Solid Tumors With HER3 AbnormalitiesUnited States, Spain, France, United Kingdom
-
Silverback TherapeuticsTerminatedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Colorectal Cancer | HER2-expressing Non-small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Daiichi Sankyo Co., Ltd.AstraZenecaCompletedMalignant Neoplasm of BreastJapan
-
Michael Morse, MDGlaxoSmithKlineCompletedMetastatic Breast CancerUnited States
-
Baylor Breast Care CenterGlaxoSmithKlineCompleted
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.TerminatedBreast CancerUnited States
-
NKGen Biotech, Inc.WithdrawnSarcoma | Cervical Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Bladder Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | HER2-positive Breast Cancer | Head and Neck Squamous Cell Carcinoma | EGF-R Positive Non-Small... and other conditions
-
Memorial Sloan Kettering Cancer CenterUniversity of Michigan; Queens Cancer Center of Queens HospitalCompletedMetastatic Breast Cancer | Central Nervous System (CNS) MetastasesUnited States
-
Dorte NielsenTerminated
-
Dartmouth-Hitchcock Medical CenterCompleted
-
Cogent Biosciences, Inc.TerminatedSolid Tumor | HER-2 Protein OverexpressionUnited States
-
Genentech, Inc.Hoffmann-La RocheCompletedMetastatic Breast CancerUnited States, Canada, China, Finland, France, Germany, Hong Kong, Italy, Korea, Republic of, Spain, United Kingdom, Brazil, Guatemala, Japan, Russian Federation, Singapore, Thailand, Latvia, Argentina, Poland, Ecuador, Mexico, Croatia and more
-
Novartis PharmaceuticalsTerminatedCancerCzechia, Poland, Russian Federation, United Kingdom, Israel
-
Shanghai Changzheng HospitalUnknown
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, China, United States, Australia, Hong Kong, Malaysia, Korea, Republic of, Singapore, Belgium, Japan, India, France, Hungary, Romania, Italy, Bulgaria, Germany, Serbia, United Kingdom, South Africa, Canada, Israel, Taiwan, Switz... and more
-
University of Kansas Medical CenterCelgene CorporationCompleted
-
Genentech, Inc.Completed
-
Shanghai Zhongshan HospitalCompleted
-
Merrimack PharmaceuticalsTerminatedBreast Cancer | HER2 Positive Breast CancerSpain, United States, Italy, France, Canada, Belgium, Austria, Germany, Czech Republic
-
Translational Oncology Research InternationalGenentech, Inc.Completed
-
Azienda Ospedaliera Ordine Mauriziano di TorinoUnknownMetastatic Breast CancerItaly
-
Beijing 302 HospitalRecruiting
-
University of Maryland, BaltimoreWithdrawnBreast Cancer With Brain MetastasisUnited States
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
Mersana TherapeuticsRecruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Non-Small Cell Lung Cancer | HER2-positive Colorectal Cancer | HER2-positive Tumors | HER2 Low Breast CancerUnited States
-
Iambic Therapeutics, IncRecruiting
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.UnknownSolid Tumor | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionChina
-
Changhoon YooCompletedCholangiocarcinoma | Biliary Tract Cancer | HER-2 Gene Amplification | HER-2 Protein OverexpressionKorea, Republic of
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
Bavarian NordicCompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHER2-positive Carcinoma | HER2-positive Primary MalignancyUnited States
-
Peking Union Medical College HospitalCompleted
-
Fudan UniversityRecruiting
-
Hunan Cancer HospitalCompletedBreast Neoplasms | HER2-positive Breast CancerChina
-
Beijing 302 HospitalRecruiting
-
Bavarian NordicCompletedBreast CancerUnited States
-
Ambrx, Inc.WithdrawnHER2 Mutation-Related Tumors | HER2 Amplified Solid TumorsUnited States
-
First Affiliated Hospital Bengbu Medical CollegeRecruitingAdenocarcinoma of the Stomach | Adenocarcinoma - GEJChina
-
ABSCINT NV/SANot yet recruiting
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited Kingdom
-
Enliven TherapeuticsRecruitingColorectal Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2 Amplification | HER2 Positive Solid TumorsUnited States